-
Je něco špatně v tomto záznamu ?
Combined in vitro and cell-based selection display method producing specific binders against IL-9 receptor in high yields
M. Huličiak, L. Biedermanová, D. Berdár, Š. Herynek, L. Kolářová, J. Tomala, P. Mikulecký, B. Schneider
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2005 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2005-01-01 do Před 1 rokem
Wiley Free Content
od 2005 do Před 1 rokem
PubMed
36637991
DOI
10.1111/febs.16726
Knihovny.cz E-zdroje
- MeSH
- cytokiny MeSH
- lidé MeSH
- peptidová knihovna MeSH
- receptory interleukinu-9 MeSH
- Saccharomyces cerevisiae * genetika MeSH
- transportní proteiny * MeSH
- vazba proteinů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We combined cell-free ribosome display and cell-based yeast display selection to build specific protein binders to the extracellular domain of the human interleukin 9 receptor alpha (IL-9Rα). The target, IL-9Rα, is the receptor involved in the signalling pathway of IL-9, a pro-inflammatory cytokine medically important for its involvement in respiratory diseases. The successive use of modified protocols of ribosome and yeast displays allowed us to combine their strengths-the virtually infinite selection power of ribosome display and the production of (mostly) properly folded and soluble proteins in yeast display. The described experimental protocol is optimized to produce binders highly specific to the target, including selectivity to common proteins such as BSA, and proteins potentially competing for the binder such as receptors of other cytokines. The binders were trained from DNA libraries of two protein scaffolds called 57aBi and 57bBi developed in our laboratory. We show that the described unconventional combination of ribosome and yeast displays is effective in developing selective small protein binders to the medically relevant molecular target.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011309
- 003
- CZ-PrNML
- 005
- 20230801132942.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/febs.16726 $2 doi
- 035 __
- $a (PubMed)36637991
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Huličiak, Maroš $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic $1 https://orcid.org/0000000299293522
- 245 10
- $a Combined in vitro and cell-based selection display method producing specific binders against IL-9 receptor in high yields / $c M. Huličiak, L. Biedermanová, D. Berdár, Š. Herynek, L. Kolářová, J. Tomala, P. Mikulecký, B. Schneider
- 520 9_
- $a We combined cell-free ribosome display and cell-based yeast display selection to build specific protein binders to the extracellular domain of the human interleukin 9 receptor alpha (IL-9Rα). The target, IL-9Rα, is the receptor involved in the signalling pathway of IL-9, a pro-inflammatory cytokine medically important for its involvement in respiratory diseases. The successive use of modified protocols of ribosome and yeast displays allowed us to combine their strengths-the virtually infinite selection power of ribosome display and the production of (mostly) properly folded and soluble proteins in yeast display. The described experimental protocol is optimized to produce binders highly specific to the target, including selectivity to common proteins such as BSA, and proteins potentially competing for the binder such as receptors of other cytokines. The binders were trained from DNA libraries of two protein scaffolds called 57aBi and 57bBi developed in our laboratory. We show that the described unconventional combination of ribosome and yeast displays is effective in developing selective small protein binders to the medically relevant molecular target.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vazba proteinů $7 D011485
- 650 12
- $a Saccharomyces cerevisiae $x genetika $7 D012441
- 650 12
- $a transportní proteiny $7 D002352
- 650 _2
- $a cytokiny $7 D016207
- 650 _2
- $a receptory interleukinu-9 $7 D053651
- 650 _2
- $a peptidová knihovna $7 D019151
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Biedermanová, Lada $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Berdár, Daniel $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Herynek, Štěpán $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Kolářová, Lucie $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Tomala, Jakub $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Mikulecký, Pavel $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic
- 700 1_
- $a Schneider, Bohdan $u Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic $1 https://orcid.org/0000000178553690
- 773 0_
- $w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 290, č. 11 (2023), s. 2993-3005
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36637991 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132939 $b ABA008
- 999 __
- $a ok $b bmc $g 1963610 $s 1197574
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 290 $c 11 $d 2993-3005 $e 20230122 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
- LZP __
- $a Pubmed-20230718